These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8347901)

  • 1. Effectiveness of an ambulatory care clinical pharmacist: a controlled trial.
    Mason JD; Colley CA
    Ann Pharmacother; 1993 May; 27(5):555-9. PubMed ID: 8347901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient care contributions of clinical pharmacists in four ambulatory care clinics.
    Hatoum HT; Witte KW; Hutchinson RA
    Hosp Pharm; 1992 Mar; 27(3):203-6, 208-9. PubMed ID: 10116720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
    Warden BA; Shapiro MD; Fazio S
    Ann Pharmacother; 2019 Dec; 53(12):1214-1219. PubMed ID: 31342786
    [No Abstract]   [Full Text] [Related]  

  • 5. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals.
    Dooley MJ; Allen KM; Doecke CJ; Galbraith KJ; Taylor GR; Bright J; Carey DL
    Br J Clin Pharmacol; 2004 Apr; 57(4):513-21. PubMed ID: 15025751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs saved and avoided from pharmacist interventions to address drug-related problems identified from outpatient clinics in Jordan.
    Al-Taani GM; Muflih SM; Al-Azzam SI; Alzoubi KH
    PLoS One; 2024; 19(6):e0302287. PubMed ID: 38843244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist value-added to neuro-oncology subspecialty clinics: A pilot study uncovers opportunities for best practices and optimal time utilization.
    Lee GW; Mathur AD; Andrick BJ; Leese E; Zally D; Gatson NTN
    J Oncol Pharm Pract; 2020 Dec; 26(8):1937-1941. PubMed ID: 32938297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit.
    Krupicka MI; Bratton SL; Sonnenthal K; Goldstein B
    Crit Care Med; 2002 Apr; 30(4):919-21. PubMed ID: 11940770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of performance metrics to assess pharmacists' activities in ambulatory care clinics.
    Schmidt L; Klink C; Iglar A; Sharpe N
    Am J Health Syst Pharm; 2017 Jan; 74(1):e76-e82. PubMed ID: 28007725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic impact of pharmacist interventions in pediatric ambulatory care clinics.
    Yung E; McNicol M; Lewis D; Fischer J; Petkus K; Sebastian S; Abdel-Rasoul M; Schmuhl K; Wise K
    J Am Pharm Assoc (2003); 2021; 61(2):198-205.e1. PubMed ID: 33358098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
    Tan EC; Stewart K; Elliott RA; George J
    Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
    DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
    J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
    de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
    J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions.
    McMullin ST; Hennenfent JA; Ritchie DJ; Huey WY; Lonergan TP; Schaiff RA; Tonn ME; Bailey TC
    Arch Intern Med; 1999 Oct; 159(19):2306-9. PubMed ID: 10547170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy.
    Lankford C; Dura J; Tran A; Lam SW; Naelitz B; Willner M; Geyer K
    J Manag Care Spec Pharm; 2021 Mar; 27(3):379-384. PubMed ID: 33645240
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a pharmacist on medication discontinuation in a hospital-based geriatric clinic.
    Phillips SL; Carr-Lopez SM
    Am J Hosp Pharm; 1990 May; 47(5):1075-9. PubMed ID: 2337097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of a Clinical Pharmacist into an Interdisciplinary Palliative Care Outpatient Clinic.
    DiScala SL; Onofrio S; Miller M; Nazario M; Silverman M
    Am J Hosp Palliat Care; 2017 Nov; 34(9):814-819. PubMed ID: 27418599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of a clinical pharmacist in a multidisciplinary amyotrophic lateral sclerosis clinic.
    Jefferies KA; Bromberg MB
    Amyotroph Lateral Scler; 2012 Feb; 13(2):233-6. PubMed ID: 22292846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.